STOCK TITAN

I-Mab to Report Financial Results for the Six Months Ended June 30, 2020 and Provide Corporate Update on August 31, 2020

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

I-Mab (Nasdaq: IMAB) announced it will report financial results for the six months ended June 30, 2020, before the market opens on August 31, 2020. A conference call is scheduled for 8:00 a.m. ET on the same day to discuss these results and provide a corporate update. I-Mab, a clinical-stage biopharmaceutical company, focuses on developing novel biologics for immuno-oncology and autoimmune diseases, aiming to bring transformational medicines to patients through innovation. The company's innovative pipeline includes over 10 drug candidates at various stages.

Positive
  • I-Mab has over 10 clinical and pre-clinical drug candidates.
  • The company employs Fast-to-PoC and Fast-to-Market strategies.
Negative
  • None.

SHANGHAI and GAITHERSBURG, Md., Aug. 6, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that it will report financial results for the six months ended June 30, 2020 before the market opens on Monday, August 31, 2020, and host a conference call to discuss the results and provide a corporate update at 8:00 a.m. ET.

I-MAB Logo (PRNewsfoto/I-Mab Biopharma)

Conference Call and Webcast Information

I-Mab will host a live conference call and webcast on August 31, 2020 at 8:00 a.m. ET. Participants must register in advance of the conference call. Details are as follows:

Registration Link:

http://apac.directeventreg.com/registration/event/8959387

Conference ID:

8959387

Upon registering, each participant will receive a dial-in number, Direct Event passcode, and a unique access PIN, which can be used to join the conference call.

A webcast replay will be archived on the Company's website for one year after the conclusion of the call at http://ir.i-mabbiopharma.com.

A telephone replay will be available approximately two hours after the conclusion of the call. To access the replay, please call +1-855-452-5696 (U.S.), +61-2-8199-0299 (International), 400-632-2162 (Mainland China), or 800-963-117 (Hong Kong). The conference ID number for the replay is 8959387.

About I-Mab

I-Mab (Nasdaq: IMAB) is a dynamic, global biotech company exclusively focused on developing biologics of novel or highly differentiated in the therapeutic areas of immuno-oncology and autoimmune diseases. The Company's mission is to bring transformational medicines to patients through innovation. I-Mab's innovative pipeline of more than 10 clinical and pre-clinical stage drug candidates is driven by the Company's Fast-to-PoC (Proof-of-Concept) and Fast-to-Market development strategies through internal R&D and global partnerships. The Company is on track to become a fully integrated end-to-end global biopharmaceutical company with cutting-edge discovery platforms, proven preclinical and clinical development expertise, and world-class GMP manufacturing capabilities. I-Mab has offices in Beijing, Shanghai, Hong Kong and Maryland, United States. For more information, please visit http://ir.i-mabbiopharma.com

For more information, please contact:

I-Mab
Jielun Zhu, CFO
E-mail: jielun.zhu@i-mabbiopharma.com
Office line: +86 21 6057 8000

Gigi Feng, Vice President and Global Head of Corporate Communications
E-mail: Gigi.Feng@i-mabbiopharma.com
Office line: +86 21 6057 8000

Investor Inquiries:

Burns McClellan, Inc. (Americas and Europe)
Steve Klass
E-mail: sklass@burnsmc.com
Office line: +1 212 213 0006

The Piacente Group, Inc. (Asia)
Emilie Wu
E-mail: emilie@thepiacentegroup.com
Office line: + 86 21 6039 8363

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/i-mab-to-report-financial-results-for-the-six-months-ended-june-30-2020-and-provide-corporate-update-on-august-31-2020-301107641.html

SOURCE I-Mab

FAQ

When will I-Mab report its financial results for the six months ended June 30, 2020?

I-Mab will report its financial results on August 31, 2020.

What time is the I-Mab conference call on August 31, 2020?

The I-Mab conference call is scheduled for 8:00 a.m. ET.

How can I participate in the I-Mab conference call?

Participants must register in advance to join the conference call.

What is the registration link for the I-Mab conference call?

The registration link is http://apac.directeventreg.com/registration/event/8959387.

I-MAB American Depositary Shares

NASDAQ:IMAB

IMAB Rankings

IMAB Latest News

IMAB Stock Data

81.46M
186.03M
11.16%
31.5%
0.63%
Biotechnology
Healthcare
Link
United States of America
Rockville